Monograph Details
|
|
Respiratory Tract
> Asthma/COPD
|
|
SPIRIVA HANDIHALER |
| Manufacturer |
|
Boehringer Ingelheim Pharmaceuticals |
| Legal Classification |
|
Rx
|
| Pharmacological Class |
|
Long-acting anticholinergic. |
| Generic Name |
|
Tiotropium (as bromide monohydrate) 18micrograms/inh; dry pwd in caps for oral inhalation; with inhaler device. |
| Indications |
|
Long-term maintenance treatment of bronchospasm due to chronic bronchitis and emphysema. |
| Children |
|
Not recommended. |
| Adults |
|
1 inh (18 micrograms) once daily, using HandiHaler inhalation device. Do not swallow caps. |
| Contraindications |
|
Allergy to atropine or its derivatives (eg, ipratropium). Not for primary treatment of acute attack. |
| Precautions |
|
Discontinue if immediate hypersensitivity reactions (eg, angioedema) or paradoxical bronchospasm occurs. Avoid getting powder into eyes. Narrow-angle glaucoma. GI or GU obstruction. Renal impairment (CrCl ≤50mL/min). Pregnancy (Cat.C). Labor and delivery. Nursing mothers. |
| Interactions |
|
Avoid other anticholinergics. |
| Adverse Reactions |
|
Dry mouth, other anticholinergic effects (eg, urinary retention/difficulty, constipation, increased heart rate, chest pain, blurred vision, glaucoma), upper respiratory or urinary tract infection, GI upset, epistaxis, rash, arthritis, cough, flu-like symptoms, paradoxical bronchospasm, angioedema. |
| How Supplied |
|
Caps (w. inh device)—6, 30 |
| Additional Resources |
|
• Related Prescribing Note |
|
|
|
|
